Expert Illustrations & Commentaries™: A Family Physicians’ Guide to Migraine Treatment – Emerging Therapies and Evolving Paradigms
Released On
December 19, 2022
Expires On
December 19, 2023
Media Type
Internet
Completion Time
60 minutes
Specialty
Neurology, Pain Management, Primary Care
Topic(s)
Migraine, Pain
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Biohaven Pharmaceuticals.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credits™
- Nurses — 1.0 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This program is intended for primary care providers, neurologists, nurse practitioners, physician assistants, and other physicians who treat patients with migraine.
Program Overview
This Expert Illustrations and Commentaries™ is a video-based program in which 2 experts discuss the etiology and management of migraine, with a focus on the role of CGRP-targeted therapy. In this activity, the faculty focus on the pathophysiology, current and emerging therapeutic strategies, and individualized care for migraine. Their discussion is enriched with the use of video animation to illustrate the mechanism of disease or mechanism of action of a therapy. The use of these animated segments helps make somewhat complicated subject matter more easily understood. This unique format is designed to help clinicians identify best practices in the management of migraine and to improve outcomes for their patients with this disease.
Learning Objectives
- Upon completion of this activity, participants should be better able to:
-
- Explain the association between the pathobiology of migraine and its clinical presentation
- Implement therapeutic strategies that reduce the risk of progressing from episodic to chronic migraine
- Evaluate clinical trial safety and efficacy data for CGRP agents used to prevent and manage migraine
- Develop a patient-centered treatment plan to prevent or reduce migraine episodes using a multidisciplinary care approach
Faculty
Jessica Ailani, MD, FAHS, FAAN
Director, MedStar Georgetown Headache Center
Vice Co-Chair, Strategic Planning
MedStar Neurology
Clinical Professor of Neurology
MedStar Georgetown University Hospital
Washington, DC
Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
Assistant Professor of Neurology
Affiliate Member, Division of Sleep Medicine
Harvard Medical School
Headache Medicine Specialist
Mass General Brigham Health Care
Harvard Vanguard Medical Associates
Boston, MA
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
- Jessica Ailani, MD, FAHS, FAAN
-
- Grant/Research Support: AbbVie, Biohaven, Eli Lilly, Zosano, Satsuma
- Consultant: AbbVie, Amgen, Aeon (Data monitoring board 2022), Axsome, Biohaven, BioDelivery Sciences International, Eli Lilly, GlaxoSmithKline, Lundbeck, Linpharma, Impel, Miravo, Pfizer, Neurolief, Neso, Satsuma, Theranica, Teva
- Stock/Shareholder: CtrlM
- Other: Editorial Boards/Steering Committee: Medscape, NeurologyLive®, Current Pain and Headache (Editor, Unusual Headache Syndromes), SELF magazine (medical editor).
- Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
-
- Grant/Research Support: AbbVie, Amgen, Biohaven, Eli Lilly, Revance, Satsuma, Theranica, Teva, Upsher-Smith
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.